Page last updated: 2024-12-07

6-amino-7-chloro-5,8-dioxoquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-amino-7-chloro-5,8-dioxoquinoline: quinone structure important in this cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96583
CHEMBL ID1098773
SCHEMBL ID1612515
MeSH IDM0070765

Synonyms (21)

Synonym
nsc84998
nsc-84998
nsc-81056
nsc81056
18892-39-2
NCIOPEN2_004387 ,
NCIOPEN2_004931
6-amino-7-chloro-5,8-quinolinequinone
6-amino-7-chloro-quinoline-5,8-dione
6-amino-7-chloro-5,8-quinolinedione
6-amino-7-chloroquinoline-5,8-dione
CHEMBL1098773 ,
unii-2q2dy57fqm
nsc 81056
2q2dy57fqm ,
6-amino-7-chloro-5,8-dioxoquinoline
5,8-dioxo-6-amino-7-chloroquinoline
SCHEMBL1612515
DTXSID10172262
5,8-quinolinedione, 6-amino-7-chloro-
bdbm50548271
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cystathionine gamma-lyaseHomo sapiens (human)IC50 (µMol)50.00000.57002.86098.0000AID1680654
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protein S100-A4Homo sapiens (human)EC50 (µMol)13.50003.80005.70007.6000AID1618872
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
epithelial to mesenchymal transitionProtein S100-A4Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein S100-A4Homo sapiens (human)
positive chemotaxisProtein S100-A4Homo sapiens (human)
cysteine metabolic processCystathionine gamma-lyaseHomo sapiens (human)
lipid metabolic processCystathionine gamma-lyaseHomo sapiens (human)
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic process via cystathionineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
transsulfurationCystathionine gamma-lyaseHomo sapiens (human)
endoplasmic reticulum unfolded protein responseCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionCystathionine gamma-lyaseHomo sapiens (human)
protein sulfhydrationCystathionine gamma-lyaseHomo sapiens (human)
protein homotetramerizationCystathionine gamma-lyaseHomo sapiens (human)
hydrogen sulfide biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of aortic smooth muscle cell differentiationCystathionine gamma-lyaseHomo sapiens (human)
cellular response to leukemia inhibitory factorCystathionine gamma-lyaseHomo sapiens (human)
negative regulation of apoptotic signaling pathwayCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
RNA bindingProtein S100-A4Homo sapiens (human)
actin bindingProtein S100-A4Homo sapiens (human)
protein bindingProtein S100-A4Homo sapiens (human)
chemoattractant activityProtein S100-A4Homo sapiens (human)
identical protein bindingProtein S100-A4Homo sapiens (human)
transition metal ion bindingProtein S100-A4Homo sapiens (human)
RAGE receptor bindingProtein S100-A4Homo sapiens (human)
calcium-dependent protein bindingProtein S100-A4Homo sapiens (human)
calcium ion bindingProtein S100-A4Homo sapiens (human)
cystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
protein bindingCystathionine gamma-lyaseHomo sapiens (human)
calmodulin bindingCystathionine gamma-lyaseHomo sapiens (human)
pyridoxal phosphate bindingCystathionine gamma-lyaseHomo sapiens (human)
identical protein bindingCystathionine gamma-lyaseHomo sapiens (human)
L-cystine L-cysteine-lyase (deaminating)Cystathionine gamma-lyaseHomo sapiens (human)
homocysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
L-cysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
selenocystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
extracellular spaceProtein S100-A4Homo sapiens (human)
extracellular regionProtein S100-A4Homo sapiens (human)
extracellular spaceProtein S100-A4Homo sapiens (human)
nucleusProtein S100-A4Homo sapiens (human)
nucleoplasmProtein S100-A4Homo sapiens (human)
cytosolProtein S100-A4Homo sapiens (human)
perinuclear region of cytoplasmProtein S100-A4Homo sapiens (human)
collagen-containing extracellular matrixProtein S100-A4Homo sapiens (human)
extracellular exosomeProtein S100-A4Homo sapiens (human)
perinuclear region of cytoplasmProtein S100-A4Homo sapiens (human)
nucleusProtein S100-A4Homo sapiens (human)
cytosolCystathionine gamma-lyaseHomo sapiens (human)
extracellular exosomeCystathionine gamma-lyaseHomo sapiens (human)
cytoplasmCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1631032Binding affinity to HIV1 MA expressed in bacterial expression system assessed as inhibition of protein binding to Sel15 RNA at 100 uM preincubated for 30 mins followed by Sel15 RNA addition measured after 30 mins by electrophoretic mobility shift assay2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
AID480963Antiinflammatory activity in human neutrophils assessed as inhibition of PMA-induced superoxide production after 20 mins by WST1 assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.
AID480962Antiproliferative activity against human T cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.
AID1631051Cytotoxicity in human MT4 cells assessed as reduction in cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
AID480961Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.
AID1631033Inactivation of glutathione in sodium phosphate buffer at pH 7.4 assessed as GSH free sulfhydryl levels at 200 uM after 1 hr by spectrophotometric analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
AID480964Antitubercular activity against Mycobacterium bovis BCG after 7 days by alamar blue assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.
AID1631036Induction of HIV1 MA cross linking assessed as formation of protein dimer at 50 uM after 2 hrs by immunoblot analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
AID1631052Cytotoxicity in human CEM-SS cells assessed as reduction in cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
AID1680654Inhibition of human CSE using L-Cys as the substrate by tandem well based HTS assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine γ-Lyase.
AID1631050Cytotoxicity in HEK293T cells assessed as reduction in cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]